Lupus Trials News
March 31, 2021 As part of the LRA’s mission to accelerate development and availability of much-needed new diagnostics and treatments...Read More
March 30, 2021 Equillium, Inc. announced positive topline data from the phase 1b EQUALISE study in patients with systemic lupus...Read More
Join LRA’s Interactive, Virtual Lupus Clinical Trials Fair on April 8th! · Learn more about an upcoming study...Read More
First Oral Treatment for Lupus Nephritis; Second Lupus Treatment to Receive FDA Approval in Past Month NEW YORK, NY. January...Read More
LuCIN Investigators Show that Stimulating the Vagus Nerve in Lupus Patients Decreases Pain and Fatigue
November 23, 2020 Up to 95% of lupus patients report pain and fatigue caused by the disease. To explore ways...Read More
Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence...Read More
30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from three clinical...Read More
October 22, 2020 Aurinia Pharmaceuticals announced that data taken from a combined analysis of two trials, AURA-LV and AURORA underscored...Read More
October 21, 2020 In a recent study published in Nature Immunology, LRA Lupus Insight Prize recipient Dr. Ignacio Sanz and colleagues found that the immune response in patients hospitalized...Read More
Lupus Clinical Trials Redefined: You Make the Difference Lupus Clinical Trials Virtual Fair Open Through November 14, 2020 Visit Fair...Read More
September 16, 2020 NEW YORK, NY. The Lupus Research Alliance welcomes positive BLISS-LN Phase 3 data published in this week’s...Read More
September 3, 2020 PPD, Inc. issued a press release today announcing its collaboration with the Lupus Research Alliance affiliate Lupus...Read More
August 25, 2020 A study started four years ago and conducted by 23andMe provided many insights about lupus as a...Read More
August 18, 2020 A newly published study conducted by many of the research investigators who receive grant support from the...Read More
2018 LRA Lupus Insight Prize Recipient Receives $15 M Grant from NIH to Study Lupus Effects on the Brain
July 27, 2020 The Lupus Research Alliance congratulates 2018 Lupus Insight Prize recipient Betty Diamond, MD and the Feinstein Institutes...Read More
July 27, 2020 A new international study published in Annals of the Rheumatic Diseases showed that belimumab (Benlysta) was safe...Read More
NEW YORK, NY. July 22. The Lupus Research Alliance congratulates Aurinia Pharmaceuticals Inc. on acceptance of its NDA filing and...Read More
June 26, 2020 The Lupus Research Alliance is disappointed at news from Janssen Pharmaceutical Companies of Johnson & Johnson that...Read More
June 22, 2020 African-Americans are more likely to develop lupus than Caucasians, but less likely to take part in clinical...Read More
Updated June 5, 2020 One of the largest meetings for rheumatologists went virtual this year to enable scientists from around...Read More
June 12, 2019 As reported by The Rheumatologist, Dr. Richard Furie provided his perspective on clinical trials in lupus in...
March 1, 2019 Proteins of the immune system, known as type I interferons, are responsible in part for manifestations of...
February 22, 2019 A study published in the peer-reviewed journal Arthritis & Rheumatology found that people with SLE and particularly...
February 22, 2019 Study results published in the peer-reviewed journal PLOS One showed that elements of physical fitness — muscle...
A study just published in Annals of Internal Medicine showed that kidney transplantation reduced deaths due to lupus nephritis— kidney inflammation caused by lupus....
An observational study published in Lupus of people with lupus found that of six factors, stress, depression and pain contributed most to...
A small randomized Phase 1 study published in Arthritis & Rheumatology found that the existing asthma treatment omalizumab (Xolair) may improve lupus...
Source: Idorsia LTD Press Release Idorsia Ltd (SIX: IDIA) announced that the first patient has been enrolled into a multiple-dose study...
A study just published in Clinical and Experimental Rheumatologyfound that exposure to periodontal bacteria on the gums around the teeth can...